{"id":"bcg-vial-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Local reaction"},{"rate":"null","effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BCG vaccine works by introducing a weakened form of the tuberculosis bacteria to the body, which triggers an immune response that helps protect against future infections.","oneSentence":"Stimulates a cell-mediated immune response against Mycobacterium tuberculosis","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:56.877Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tuberculosis"}]},"trialDetails":[{"nctId":"NCT05947890","phase":"PHASE2","title":"Evaluating the Safety and Immunogenicity of MTBVAC","status":"RECRUITING","sponsor":"HIV Vaccine Trials Network","startDate":"2024-01-30","conditions":"HIV I Infection, Tuberculosis","enrollment":276},{"nctId":"NCT04658680","phase":"PHASE4","title":"Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bandim Health Project","startDate":"2021-02-25","conditions":"Infant Mortality, BCG","enrollment":22800},{"nctId":"NCT07094711","phase":"PHASE2","title":"Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-30","conditions":"Mycobacterium Avium-intracellulare Infection, Mycobacterium Infections, Nontuberculous","enrollment":48},{"nctId":"NCT06997367","phase":"PHASE2","title":"Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)","status":"RECRUITING","sponsor":"Bharat Biotech International Limited","startDate":"2025-03-01","conditions":"Tuberculosis (TB)","enrollment":164},{"nctId":"NCT06438978","phase":"PHASE1","title":"Tuberculosis Vaccine in Healthy Indian Adults","status":"COMPLETED","sponsor":"Bharat Biotech International Limited","startDate":"2024-01-19","conditions":"Tuberculosis","enrollment":30},{"nctId":"NCT04975178","phase":"PHASE3","title":"Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa","status":"RECRUITING","sponsor":"Biofabri, S.L","startDate":"2022-10-17","conditions":"Tuberculosis","enrollment":7120},{"nctId":"NCT04351685","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2020-11-09","conditions":"Mycobacterium Tuberculosis Infection","enrollment":6940},{"nctId":"NCT03888924","phase":"PHASE2","title":"Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)","status":"RECRUITING","sponsor":"S. Andrea Hospital","startDate":"2019-06-17","conditions":"Multiple Sclerosis","enrollment":100},{"nctId":"NCT04348370","phase":"PHASE4","title":"BCG Vaccine for Health Care Workers as Defense Against COVID 19","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2020-04-20","conditions":"Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere","enrollment":659},{"nctId":"NCT04659941","phase":"PHASE2","title":"Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers","status":"UNKNOWN","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2020-10-01","conditions":"COVID 19 Vaccine","enrollment":752},{"nctId":"NCT05124340","phase":"PHASE2","title":"Safety and Tuberculin Conversion Following BCG Vaccination","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2021-12-01","conditions":"BCG Vaccination Reaction","enrollment":220},{"nctId":"NCT04449926","phase":"PHASE2","title":"BCG and Plasma Amyloid in Non-Demented Adults","status":"COMPLETED","sponsor":"Mindful Diagnostics and Therapeutics, LLC","startDate":"2020-11-09","conditions":"Alzheimer Disease, Late Onset","enrollment":49},{"nctId":"NCT04632537","phase":"PHASE3","title":"BCG Vaccination to Prevent COVID-19","status":"WITHDRAWN","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2020-12-07","conditions":"COVID-19","enrollment":""},{"nctId":"NCT02075203","phase":"PHASE2","title":"Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents","status":"COMPLETED","sponsor":"Aeras","startDate":"2014-02","conditions":"Tuberculosis","enrollment":989},{"nctId":"NCT00329849","phase":"PHASE3","title":"Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2006-05","conditions":"Meningococcal Disease","enrollment":1500},{"nctId":"NCT02420444","phase":"PHASE1","title":"A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults","status":"COMPLETED","sponsor":"Aeras","startDate":"2011-01","conditions":"Tuberculosis","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":27,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BCG vial vaccine","genericName":"BCG vial vaccine","companyName":"PT Bio Farma","companyId":"pt-bio-farma","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stimulates a cell-mediated immune response against Mycobacterium tuberculosis Used for Tuberculosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}